This website is intended for use by Australian healthcare professionals only (registration and verification is required) and is designed to comply with Australian law and regulations only. If you are a patient seeking medical advice, please contact your healthcare professional.

PBS INFORMATION: Authority Required (WRITTEN) for initial and first continuing prescriptions. Authority Required (STREAMLINED) for continuing subsequent prescriptions. Refer to PBS Schedule for full authority information.

AMGEVITA (adalimumab): Please review the full product information before prescribing available at or on request from Amgen Australia Pty Ltd. PH: 1800 803 638 OR

For more information on AMGEVITA or to report an adverse event or product complaint involving AMGEVITA please contact Amgen Medical Information on 1800 803 638 or email or visit

AU-16456. Date of Preparation: May 2022